Companies ›Healthcare ›HVAX.NS

HVAX.NS — NSE (India) Advanced Medical Equipment & Technology

HVAX Technologies Ltd

$826,45

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

—

ROE

—

Net margin

—

Debt / equity

0,96

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

HVAX Technologies Ltd designs and manufactures advanced medical equipment and technology solutions for healthcare providers and institutions.

Business. HVAX Technologies Ltd (HVAX.NS) is an Indian company operating in the Advanced Medical Equipment & Technology industry within the Healthcare Services & Equipment sector. The firm is primarily listed on the National Stock Exchange of India (NSE). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of advanced medical equipment and technology.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryAdvanced Medical Equipment & Technology

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability

—

not yet wired

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning HVAX.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to HVAX.NS. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

HVAX Technologies Ltd (HVAX.NS) is an Indian company operating in the Advanced Medical Equipment & Technology industry within the Healthcare Services & Equipment sector. The firm is primarily listed on the National Stock Exchange of India (NSE). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of advanced medical equipment and technology.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryAdvanced Medical Equipment & Technology

AI synthesis

GENERATED

HVAX Technologies Ltd maintains a debt-to-equity ratio of 0.96, indicating a balanced capital structure with moderate leverage. The company's current ratio of 1.23 suggests it has sufficient short-term assets to cover its short-term liabilities, though the margin is narrow. Despite reporting negative operating cash flow of INR 66.53 million, the company generated positive free cash flow of INR 56.66 million, which may support ongoing operations and reinvestment.

The company's financial performance shows mixed signals. While the free cash flow is positive, the negative operating cash flow raises concerns about the sustainability of its core operations. The debt-to-equity ratio of 0.96 is in line with industry norms, but the negative net cash position after subtracting total debt indicates potential liquidity constraints.

HVAX Technologies Ltd operates in a single business segment focused on advanced medical equipment and technology. The company's geographic exposure is not disclosed in the available data, making it difficult to assess revenue concentration risks.

The company's growth trajectory is uncertain. The available data does not provide specific revenue growth projections for the current or next fiscal year, making it challenging to assess future performance. The company's capital expenditure of INR 5.395 million suggests a modest investment in long-term assets.

The risk assessment indicates medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt highlights potential liquidity constraints. The company's dilution risk is low, as there is no indication of significant share issuance or dilution potential.

Recent events and filings do not provide specific details about the company's operations or strategic initiatives. The available data does not include recent transcripts or filings that could provide insight into the company's performance or future plans.

Key takeaways

HVAX Technologies Ltd maintains a balanced capital structure with a debt-to-equity ratio of 0.96.
The company's current ratio of 1.23 indicates it has sufficient short-term assets to cover its short-term liabilities.
Despite positive free cash flow, the company reports negative operating cash flow, raising concerns about the sustainability of its core operations.
The company's financial performance shows mixed signals, with a debt-to-equity ratio in line with industry norms but a negative net cash position after subtracting total debt.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data.
The risk assessment indicates medium liquidity risk and low dilution risk, with a key flag of negative net cash after subtracting total debt.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation FY

Market price

$826,45

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$224.4M

Net cashⓘ

-$179.1M

Current ratioⓘ

1.2

Debt / equityⓘ

1.0

ROAⓘ

—

ROEⓘ

—

Cash conversionⓘ

—

CapEx / revenueⓘ

—

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

D/E0,96Bottom quartile

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt

Source documents

HVAX Technologies Ltd Market data — financials · 2026-05-28

Ownership & reference

Leadership

Nirbhaynarayan SinghExecutive Chairman of the Board

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

HVAX.NSCanonical

NSE (India) · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation FY

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Leadership

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread